1 Study Coverage
    1.1 Bio-active Peptides Product Introduction
    1.2 Market by Type
        1.2.1 Global Bio-active Peptides Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Natural Bio-active Peptides
        1.2.3 Artificial Synthesis Bio-active Peptides
    1.3 Market by Application
        1.3.1 Global Bio-active Peptides Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Food
        1.3.3 Health Products
        1.3.4 Pharmaceutical
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Bio-active Peptides Production
    2.1 Global Bio-active Peptides Production Capacity (2017-2028)
    2.2 Global Bio-active Peptides Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Bio-active Peptides Production by Region
        2.3.1 Global Bio-active Peptides Historic Production by Region (2017-2022)
        2.3.2 Global Bio-active Peptides Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
3 Global Bio-active Peptides Sales in Volume & Value Estimates and Forecasts
    3.1 Global Bio-active Peptides Sales Estimates and Forecasts 2017-2028
    3.2 Global Bio-active Peptides Revenue Estimates and Forecasts 2017-2028
    3.3 Global Bio-active Peptides Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Bio-active Peptides Sales by Region
        3.4.1 Global Bio-active Peptides Sales by Region (2017-2022)
        3.4.2 Global Sales Bio-active Peptides by Region (2023-2028)
    3.5 Global Bio-active Peptides Revenue by Region
        3.5.1 Global Bio-active Peptides Revenue by Region (2017-2022)
        3.5.2 Global Bio-active Peptides Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Bio-active Peptides Production Capacity by Manufacturers
    4.2 Global Bio-active Peptides Sales by Manufacturers
        4.2.1 Global Bio-active Peptides Sales by Manufacturers (2017-2022)
        4.2.2 Global Bio-active Peptides Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Bio-active Peptides in 2021
    4.3 Global Bio-active Peptides Revenue by Manufacturers
        4.3.1 Global Bio-active Peptides Revenue by Manufacturers (2017-2022)
        4.3.2 Global Bio-active Peptides Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Bio-active Peptides Revenue in 2021
    4.4 Global Bio-active Peptides Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Bio-active Peptides Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Bio-active Peptides Sales by Type
        5.1.1 Global Bio-active Peptides Historical Sales by Type (2017-2022)
        5.1.2 Global Bio-active Peptides Forecasted Sales by Type (2023-2028)
        5.1.3 Global Bio-active Peptides Sales Market Share by Type (2017-2028)
    5.2 Global Bio-active Peptides Revenue by Type
        5.2.1 Global Bio-active Peptides Historical Revenue by Type (2017-2022)
        5.2.2 Global Bio-active Peptides Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Bio-active Peptides Revenue Market Share by Type (2017-2028)
    5.3 Global Bio-active Peptides Price by Type
        5.3.1 Global Bio-active Peptides Price by Type (2017-2022)
        5.3.2 Global Bio-active Peptides Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Bio-active Peptides Sales by Application
        6.1.1 Global Bio-active Peptides Historical Sales by Application (2017-2022)
        6.1.2 Global Bio-active Peptides Forecasted Sales by Application (2023-2028)
        6.1.3 Global Bio-active Peptides Sales Market Share by Application (2017-2028)
    6.2 Global Bio-active Peptides Revenue by Application
        6.2.1 Global Bio-active Peptides Historical Revenue by Application (2017-2022)
        6.2.2 Global Bio-active Peptides Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Bio-active Peptides Revenue Market Share by Application (2017-2028)
    6.3 Global Bio-active Peptides Price by Application
        6.3.1 Global Bio-active Peptides Price by Application (2017-2022)
        6.3.2 Global Bio-active Peptides Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Bio-active Peptides Market Size by Type
        7.1.1 North America Bio-active Peptides Sales by Type (2017-2028)
        7.1.2 North America Bio-active Peptides Revenue by Type (2017-2028)
    7.2 North America Bio-active Peptides Market Size by Application
        7.2.1 North America Bio-active Peptides Sales by Application (2017-2028)
        7.2.2 North America Bio-active Peptides Revenue by Application (2017-2028)
    7.3 North America Bio-active Peptides Sales by Country
        7.3.1 North America Bio-active Peptides Sales by Country (2017-2028)
        7.3.2 North America Bio-active Peptides Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Bio-active Peptides Market Size by Type
        8.1.1 Europe Bio-active Peptides Sales by Type (2017-2028)
        8.1.2 Europe Bio-active Peptides Revenue by Type (2017-2028)
    8.2 Europe Bio-active Peptides Market Size by Application
        8.2.1 Europe Bio-active Peptides Sales by Application (2017-2028)
        8.2.2 Europe Bio-active Peptides Revenue by Application (2017-2028)
    8.3 Europe Bio-active Peptides Sales by Country
        8.3.1 Europe Bio-active Peptides Sales by Country (2017-2028)
        8.3.2 Europe Bio-active Peptides Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Bio-active Peptides Market Size by Type
        9.1.1 Asia Pacific Bio-active Peptides Sales by Type (2017-2028)
        9.1.2 Asia Pacific Bio-active Peptides Revenue by Type (2017-2028)
    9.2 Asia Pacific Bio-active Peptides Market Size by Application
        9.2.1 Asia Pacific Bio-active Peptides Sales by Application (2017-2028)
        9.2.2 Asia Pacific Bio-active Peptides Revenue by Application (2017-2028)
    9.3 Asia Pacific Bio-active Peptides Sales by Region
        9.3.1 Asia Pacific Bio-active Peptides Sales by Region (2017-2028)
        9.3.2 Asia Pacific Bio-active Peptides Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Bio-active Peptides Market Size by Type
        10.1.1 Latin America Bio-active Peptides Sales by Type (2017-2028)
        10.1.2 Latin America Bio-active Peptides Revenue by Type (2017-2028)
    10.2 Latin America Bio-active Peptides Market Size by Application
        10.2.1 Latin America Bio-active Peptides Sales by Application (2017-2028)
        10.2.2 Latin America Bio-active Peptides Revenue by Application (2017-2028)
    10.3 Latin America Bio-active Peptides Sales by Country
        10.3.1 Latin America Bio-active Peptides Sales by Country (2017-2028)
        10.3.2 Latin America Bio-active Peptides Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Bio-active Peptides Market Size by Type
        11.1.1 Middle East and Africa Bio-active Peptides Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Bio-active Peptides Revenue by Type (2017-2028)
    11.2 Middle East and Africa Bio-active Peptides Market Size by Application
        11.2.1 Middle East and Africa Bio-active Peptides Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Bio-active Peptides Revenue by Application (2017-2028)
    11.3 Middle East and Africa Bio-active Peptides Sales by Country
        11.3.1 Middle East and Africa Bio-active Peptides Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Bio-active Peptides Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 UAE
12 Corporate Profiles
    12.1 Archer Daniels Midland Company
        12.1.1 Archer Daniels Midland Company Corporation Information
        12.1.2 Archer Daniels Midland Company Overview
        12.1.3 Archer Daniels Midland Company Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Archer Daniels Midland Company Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Archer Daniels Midland Company Recent Developments
    12.2 Seagarden AS
        12.2.1 Seagarden AS Corporation Information
        12.2.2 Seagarden AS Overview
        12.2.3 Seagarden AS Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Seagarden AS Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Seagarden AS Recent Developments
    12.3 Phermpep
        12.3.1 Phermpep Corporation Information
        12.3.2 Phermpep Overview
        12.3.3 Phermpep Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Phermpep Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Phermpep Recent Developments
    12.4 Arlak Biotech
        12.4.1 Arlak Biotech Corporation Information
        12.4.2 Arlak Biotech Overview
        12.4.3 Arlak Biotech Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Arlak Biotech Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Arlak Biotech Recent Developments
    12.5 Naturade
        12.5.1 Naturade Corporation Information
        12.5.2 Naturade Overview
        12.5.3 Naturade Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Naturade Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Naturade Recent Developments
    12.6 Royal DSM
        12.6.1 Royal DSM Corporation Information
        12.6.2 Royal DSM Overview
        12.6.3 Royal DSM Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Royal DSM Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Royal DSM Recent Developments
    12.7 MYOS RENS Technology
        12.7.1 MYOS RENS Technology Corporation Information
        12.7.2 MYOS RENS Technology Overview
        12.7.3 MYOS RENS Technology Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 MYOS RENS Technology Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 MYOS RENS Technology Recent Developments
    12.8 Natural Factors Nutritional Products
        12.8.1 Natural Factors Nutritional Products Corporation Information
        12.8.2 Natural Factors Nutritional Products Overview
        12.8.3 Natural Factors Nutritional Products Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Natural Factors Nutritional Products Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Natural Factors Nutritional Products Recent Developments
    12.9 Valio Oy
        12.9.1 Valio Oy Corporation Information
        12.9.2 Valio Oy Overview
        12.9.3 Valio Oy Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.9.4 Valio Oy Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 Valio Oy Recent Developments
    12.10 Wuhan Lullaby Pharmaceutical Chemical
        12.10.1 Wuhan Lullaby Pharmaceutical Chemical Corporation Information
        12.10.2 Wuhan Lullaby Pharmaceutical Chemical Overview
        12.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.10.4 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments
    12.11 Wuhan Dahua Pharmaceutical
        12.11.1 Wuhan Dahua Pharmaceutical Corporation Information
        12.11.2 Wuhan Dahua Pharmaceutical Overview
        12.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.11.4 Wuhan Dahua Pharmaceutical Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.11.5 Wuhan Dahua Pharmaceutical Recent Developments
    12.12 Pharma Foods International
        12.12.1 Pharma Foods International Corporation Information
        12.12.2 Pharma Foods International Overview
        12.12.3 Pharma Foods International Bio-active Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
        12.12.4 Pharma Foods International Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
        12.12.5 Pharma Foods International Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Bio-active Peptides Industry Chain Analysis
    13.2 Bio-active Peptides Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Bio-active Peptides Production Mode & Process
    13.4 Bio-active Peptides Sales and Marketing
        13.4.1 Bio-active Peptides Sales Channels
        13.4.2 Bio-active Peptides Distributors
    13.5 Bio-active Peptides Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Bio-active Peptides Industry Trends
    14.2 Bio-active Peptides Market Drivers
    14.3 Bio-active Peptides Market Challenges
    14.4 Bio-active Peptides Market Restraints
15 Key Finding in The Global Bio-active Peptides Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Bio-active Peptides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Natural Bio-active Peptides
    Table 3. Major Manufacturers of Artificial Synthesis Bio-active Peptides
    Table 4. Global Bio-active Peptides Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 5. Global Bio-active Peptides Production by Region: 2017 VS 2021 VS 2028 (Ton)
    Table 6. Global Bio-active Peptides Production by Region (2017-2022) & (Ton)
    Table 7. Global Bio-active Peptides Production Market Share by Region (2017-2022)
    Table 8. Global Bio-active Peptides Production by Region (2023-2028) & (Ton)
    Table 9. Global Bio-active Peptides Production Market Share by Region (2023-2028)
    Table 10. Global Bio-active Peptides Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Bio-active Peptides Sales by Region (2017-2022) & (Ton)
    Table 12. Global Bio-active Peptides Sales Market Share by Region (2017-2022)
    Table 13. Global Bio-active Peptides Sales by Region (2023-2028) & (Ton)
    Table 14. Global Bio-active Peptides Sales Market Share by Region (2023-2028)
    Table 15. Global Bio-active Peptides Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Bio-active Peptides Revenue Market Share by Region (2017-2022)
    Table 17. Global Bio-active Peptides Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Bio-active Peptides Revenue Market Share by Region (2023-2028)
    Table 19. Global Bio-active Peptides Production Capacity by Manufacturers (2017-2022) & (Ton)
    Table 20. Global Bio-active Peptides Capacity Market Share by Manufacturers (2017-2022)
    Table 21. Global Bio-active Peptides Sales by Manufacturers (2017-2022) & (Ton)
    Table 22. Global Bio-active Peptides Sales Market Share by Manufacturers (2017-2022)
    Table 23. Global Bio-active Peptides Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global Bio-active Peptides Revenue Share by Manufacturers (2017-2022)
    Table 25. Bio-active Peptides Price by Manufacturers 2017-2022 (US$/Ton)
    Table 26. Global Bio-active Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Bio-active Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-active Peptides as of 2021)
    Table 28. Bio-active Peptides Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Bio-active Peptides Product Offered
    Table 30. Date of Manufacturers Enter into Bio-active Peptides Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Bio-active Peptides Sales by Type (2017-2022) & (Ton)
    Table 33. Global Bio-active Peptides Sales by Type (2023-2028) & (Ton)
    Table 34. Global Bio-active Peptides Sales Share by Type (2017-2022)
    Table 35. Global Bio-active Peptides Sales Share by Type (2023-2028)
    Table 36. Global Bio-active Peptides Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Global Bio-active Peptides Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Global Bio-active Peptides Revenue Share by Type (2017-2022)
    Table 39. Global Bio-active Peptides Revenue Share by Type (2023-2028)
    Table 40. Bio-active Peptides Price by Type (2017-2022) & (US$/Ton)
    Table 41. Global Bio-active Peptides Price Forecast by Type (2023-2028) & (US$/Ton)
    Table 42. Global Bio-active Peptides Sales by Application (2017-2022) & (Ton)
    Table 43. Global Bio-active Peptides Sales by Application (2023-2028) & (Ton)
    Table 44. Global Bio-active Peptides Sales Share by Application (2017-2022)
    Table 45. Global Bio-active Peptides Sales Share by Application (2023-2028)
    Table 46. Global Bio-active Peptides Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Bio-active Peptides Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global Bio-active Peptides Revenue Share by Application (2017-2022)
    Table 49. Global Bio-active Peptides Revenue Share by Application (2023-2028)
    Table 50. Bio-active Peptides Price by Application (2017-2022) & (US$/Ton)
    Table 51. Global Bio-active Peptides Price Forecast by Application (2023-2028) & (US$/Ton)
    Table 52. North America Bio-active Peptides Sales by Type (2017-2022) & (Ton)
    Table 53. North America Bio-active Peptides Sales by Type (2023-2028) & (Ton)
    Table 54. North America Bio-active Peptides Revenue by Type (2017-2022) & (US$ Million)
    Table 55. North America Bio-active Peptides Revenue by Type (2023-2028) & (US$ Million)
    Table 56. North America Bio-active Peptides Sales by Application (2017-2022) & (Ton)
    Table 57. North America Bio-active Peptides Sales by Application (2023-2028) & (Ton)
    Table 58. North America Bio-active Peptides Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America Bio-active Peptides Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America Bio-active Peptides Sales by Country (2017-2022) & (Ton)
    Table 61. North America Bio-active Peptides Sales by Country (2023-2028) & (Ton)
    Table 62. North America Bio-active Peptides Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America Bio-active Peptides Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe Bio-active Peptides Sales by Type (2017-2022) & (Ton)
    Table 65. Europe Bio-active Peptides Sales by Type (2023-2028) & (Ton)
    Table 66. Europe Bio-active Peptides Revenue by Type (2017-2022) & (US$ Million)
    Table 67. Europe Bio-active Peptides Revenue by Type (2023-2028) & (US$ Million)
    Table 68. Europe Bio-active Peptides Sales by Application (2017-2022) & (Ton)
    Table 69. Europe Bio-active Peptides Sales by Application (2023-2028) & (Ton)
    Table 70. Europe Bio-active Peptides Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe Bio-active Peptides Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe Bio-active Peptides Sales by Country (2017-2022) & (Ton)
    Table 73. Europe Bio-active Peptides Sales by Country (2023-2028) & (Ton)
    Table 74. Europe Bio-active Peptides Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe Bio-active Peptides Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Bio-active Peptides Sales by Type (2017-2022) & (Ton)
    Table 77. Asia Pacific Bio-active Peptides Sales by Type (2023-2028) & (Ton)
    Table 78. Asia Pacific Bio-active Peptides Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Bio-active Peptides Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Bio-active Peptides Sales by Application (2017-2022) & (Ton)
    Table 81. Asia Pacific Bio-active Peptides Sales by Application (2023-2028) & (Ton)
    Table 82. Asia Pacific Bio-active Peptides Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Bio-active Peptides Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Bio-active Peptides Sales by Region (2017-2022) & (Ton)
    Table 85. Asia Pacific Bio-active Peptides Sales by Region (2023-2028) & (Ton)
    Table 86. Asia Pacific Bio-active Peptides Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Bio-active Peptides Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America Bio-active Peptides Sales by Type (2017-2022) & (Ton)
    Table 89. Latin America Bio-active Peptides Sales by Type (2023-2028) & (Ton)
    Table 90. Latin America Bio-active Peptides Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Latin America Bio-active Peptides Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Latin America Bio-active Peptides Sales by Application (2017-2022) & (Ton)
    Table 93. Latin America Bio-active Peptides Sales by Application (2023-2028) & (Ton)
    Table 94. Latin America Bio-active Peptides Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America Bio-active Peptides Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America Bio-active Peptides Sales by Country (2017-2022) & (Ton)
    Table 97. Latin America Bio-active Peptides Sales by Country (2023-2028) & (Ton)
    Table 98. Latin America Bio-active Peptides Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America Bio-active Peptides Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Bio-active Peptides Sales by Type (2017-2022) & (Ton)
    Table 101. Middle East and Africa Bio-active Peptides Sales by Type (2023-2028) & (Ton)
    Table 102. Middle East and Africa Bio-active Peptides Revenue by Type (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Bio-active Peptides Revenue by Type (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Bio-active Peptides Sales by Application (2017-2022) & (Ton)
    Table 105. Middle East and Africa Bio-active Peptides Sales by Application (2023-2028) & (Ton)
    Table 106. Middle East and Africa Bio-active Peptides Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Bio-active Peptides Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa Bio-active Peptides Sales by Country (2017-2022) & (Ton)
    Table 109. Middle East and Africa Bio-active Peptides Sales by Country (2023-2028) & (Ton)
    Table 110. Middle East and Africa Bio-active Peptides Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa Bio-active Peptides Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Archer Daniels Midland Company Corporation Information
    Table 113. Archer Daniels Midland Company Description and Major Businesses
    Table 114. Archer Daniels Midland Company Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 115. Archer Daniels Midland Company Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Archer Daniels Midland Company Recent Development
    Table 117. Seagarden AS Corporation Information
    Table 118. Seagarden AS Description and Major Businesses
    Table 119. Seagarden AS Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 120. Seagarden AS Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Seagarden AS Recent Development
    Table 122. Phermpep Corporation Information
    Table 123. Phermpep Description and Major Businesses
    Table 124. Phermpep Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 125. Phermpep Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Phermpep Recent Development
    Table 127. Arlak Biotech Corporation Information
    Table 128. Arlak Biotech Description and Major Businesses
    Table 129. Arlak Biotech Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 130. Arlak Biotech Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Arlak Biotech Recent Development
    Table 132. Naturade Corporation Information
    Table 133. Naturade Description and Major Businesses
    Table 134. Naturade Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 135. Naturade Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Naturade Recent Development
    Table 137. Royal DSM Corporation Information
    Table 138. Royal DSM Description and Major Businesses
    Table 139. Royal DSM Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 140. Royal DSM Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Royal DSM Recent Development
    Table 142. MYOS RENS Technology Corporation Information
    Table 143. MYOS RENS Technology Description and Major Businesses
    Table 144. MYOS RENS Technology Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 145. MYOS RENS Technology Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. MYOS RENS Technology Recent Development
    Table 147. Natural Factors Nutritional Products Corporation Information
    Table 148. Natural Factors Nutritional Products Description and Major Businesses
    Table 149. Natural Factors Nutritional Products Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 150. Natural Factors Nutritional Products Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Natural Factors Nutritional Products Recent Development
    Table 152. Valio Oy Corporation Information
    Table 153. Valio Oy Description and Major Businesses
    Table 154. Valio Oy Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 155. Valio Oy Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Valio Oy Recent Development
    Table 157. Wuhan Lullaby Pharmaceutical Chemical Corporation Information
    Table 158. Wuhan Lullaby Pharmaceutical Chemical Description and Major Businesses
    Table 159. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 160. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Wuhan Lullaby Pharmaceutical Chemical Recent Development
    Table 162. Wuhan Dahua Pharmaceutical Corporation Information
    Table 163. Wuhan Dahua Pharmaceutical Description and Major Businesses
    Table 164. Wuhan Dahua Pharmaceutical Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 165. Wuhan Dahua Pharmaceutical Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Wuhan Dahua Pharmaceutical Recent Development
    Table 167. Pharma Foods International Corporation Information
    Table 168. Pharma Foods International Description and Major Businesses
    Table 169. Pharma Foods International Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 170. Pharma Foods International Bio-active Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Pharma Foods International Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Bio-active Peptides Distributors List
    Table 175. Bio-active Peptides Customers List
    Table 176. Bio-active Peptides Market Trends
    Table 177. Bio-active Peptides Market Drivers
    Table 178. Bio-active Peptides Market Challenges
    Table 179. Bio-active Peptides Market Restraints
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bio-active Peptides Product Picture
    Figure 2. Global Bio-active Peptides Market Share by Type in 2021 & 2028
    Figure 3. Natural Bio-active Peptides Product Picture
    Figure 4. Artificial Synthesis Bio-active Peptides Product Picture
    Figure 5. Global Bio-active Peptides Market Share by Application in 2021 & 2028
    Figure 6. Food
    Figure 7. Health Products
    Figure 8. Pharmaceutical
    Figure 9. Other
    Figure 10. Bio-active Peptides Report Years Considered
    Figure 11. Global Bio-active Peptides Capacity, Production and Utilization (2017-2028) & (Ton)
    Figure 12. Global Bio-active Peptides Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Bio-active Peptides Production Market Share by Region (2017-2022)
    Figure 14. Global Bio-active Peptides Production Market Share by Region (2023-2028)
    Figure 15. Bio-active Peptides Production Growth Rate in North America (2017-2028) & (Ton)
    Figure 16. Bio-active Peptides Production Growth Rate in Europe (2017-2028) & (Ton)
    Figure 17. Bio-active Peptides Production Growth Rate in China (2017-2028) & (Ton)
    Figure 18. Bio-active Peptides Production Growth Rate in Japan (2017-2028) & (Ton)
    Figure 19. Global Bio-active Peptides Sales 2017-2028 (Ton)
    Figure 20. Global Bio-active Peptides Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 21. Global Bio-active Peptides Revenue 2017-2028 (US$ Million)
    Figure 22. Global Bio-active Peptides Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 23. Global Bio-active Peptides Sales Market Share by Region (2017-2022)
    Figure 24. Global Bio-active Peptides Sales Market Share by Region (2023-2028)
    Figure 25. North America Bio-active Peptides Sales YoY (2017-2028) & (Ton)
    Figure 26. North America Bio-active Peptides Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Bio-active Peptides Sales YoY (2017-2028) & (Ton)
    Figure 28. Europe Bio-active Peptides Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Bio-active Peptides Sales YoY (2017-2028) & (Ton)
    Figure 30. Asia-Pacific Bio-active Peptides Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Latin America Bio-active Peptides Sales YoY (2017-2028) & (Ton)
    Figure 32. Latin America Bio-active Peptides Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. Middle East & Africa Bio-active Peptides Sales YoY (2017-2028) & (Ton)
    Figure 34. Middle East & Africa Bio-active Peptides Revenue YoY (2017-2028) & (US$ Million)
    Figure 35. The Bio-active Peptides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 36. The Top 5 and 10 Largest Manufacturers of Bio-active Peptides in the World: Market Share by Bio-active Peptides Revenue in 2021
    Figure 37. Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 38. Global Bio-active Peptides Sales Market Share by Type (2017-2028)
    Figure 39. Global Bio-active Peptides Revenue Market Share by Type (2017-2028)
    Figure 40. Global Bio-active Peptides Sales Market Share by Application (2017-2028)
    Figure 41. Global Bio-active Peptides Revenue Market Share by Application (2017-2028)
    Figure 42. North America Bio-active Peptides Sales Market Share by Type (2017-2028)
    Figure 43. North America Bio-active Peptides Revenue Market Share by Type (2017-2028)
    Figure 44. North America Bio-active Peptides Sales Market Share by Application (2017-2028)
    Figure 45. North America Bio-active Peptides Revenue Market Share by Application (2017-2028)
    Figure 46. North America Bio-active Peptides Sales Share by Country (2017-2028)
    Figure 47. North America Bio-active Peptides Revenue Share by Country (2017-2028)
    Figure 48. U.S. Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 49. Canada Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 50. Europe Bio-active Peptides Sales Market Share by Type (2017-2028)
    Figure 51. Europe Bio-active Peptides Revenue Market Share by Type (2017-2028)
    Figure 52. Europe Bio-active Peptides Sales Market Share by Application (2017-2028)
    Figure 53. Europe Bio-active Peptides Revenue Market Share by Application (2017-2028)
    Figure 54. Europe Bio-active Peptides Sales Share by Country (2017-2028)
    Figure 55. Europe Bio-active Peptides Revenue Share by Country (2017-2028)
    Figure 56. Germany Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 57. France Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 58. U.K. Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 59. Italy Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 60. Russia Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 61. Asia Pacific Bio-active Peptides Sales Market Share by Type (2017-2028)
    Figure 62. Asia Pacific Bio-active Peptides Revenue Market Share by Type (2017-2028)
    Figure 63. Asia Pacific Bio-active Peptides Sales Market Share by Application (2017-2028)
    Figure 64. Asia Pacific Bio-active Peptides Revenue Market Share by Application (2017-2028)
    Figure 65. Asia Pacific Bio-active Peptides Sales Share by Region (2017-2028)
    Figure 66. Asia Pacific Bio-active Peptides Revenue Share by Region (2017-2028)
    Figure 67. China Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 68. Japan Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 69. South Korea Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 70. India Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 71. Australia Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 72. Taiwan Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 73. Indonesia Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 74. Thailand Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 75. Malaysia Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 76. Philippines Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 77. Latin America Bio-active Peptides Sales Market Share by Type (2017-2028)
    Figure 78. Latin America Bio-active Peptides Revenue Market Share by Type (2017-2028)
    Figure 79. Latin America Bio-active Peptides Sales Market Share by Application (2017-2028)
    Figure 80. Latin America Bio-active Peptides Revenue Market Share by Application (2017-2028)
    Figure 81. Latin America Bio-active Peptides Sales Share by Country (2017-2028)
    Figure 82. Latin America Bio-active Peptides Revenue Share by Country (2017-2028)
    Figure 83. Mexico Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 84. Brazil Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 85. Argentina Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 86. Middle East and Africa Bio-active Peptides Sales Market Share by Type (2017-2028)
    Figure 87. Middle East and Africa Bio-active Peptides Revenue Market Share by Type (2017-2028)
    Figure 88. Middle East and Africa Bio-active Peptides Sales Market Share by Application (2017-2028)
    Figure 89. Middle East and Africa Bio-active Peptides Revenue Market Share by Application (2017-2028)
    Figure 90. Middle East and Africa Bio-active Peptides Sales Share by Country (2017-2028)
    Figure 91. Middle East and Africa Bio-active Peptides Revenue Share by Country (2017-2028)
    Figure 92. Turkey Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 93. Saudi Arabia Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 94. UAE Bio-active Peptides Revenue (2017-2028) & (US$ Million)
    Figure 95. Bio-active Peptides Value Chain
    Figure 96. Bio-active Peptides Production Process
    Figure 97. Channels of Distribution
    Figure 98. Distributors Profiles
    Figure 99. Bottom-up and Top-down Approaches for This Report
    Figure 100. Data Triangulation
    Figure 101. Key Executives Interviewed